Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study
Background/Purpose: MVC-COV1901 is a protein vaccine based on the same SARS-CoV-2 strain used in mRNA vaccine mRNA-1273. Data are lacking on immunogenicity and safety of MVC-COV1901 as heterologous boost for people already received one dose of mRNA-1273. Methods: This is a randomized, double-blind t...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2023-11-01
|
| Seri Bilgileri: | Journal of the Formosan Medical Association |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S0929664623001997 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|